WisdomTree, a provider of funds and listed products (“ETFs” and “ETPs”, respectively), today announced the launch of the WisdomTree BioRevolution UCITS ETF (WDNA). The WDNA, which is listed as of today on the London Stock Exchange and Börse Xetra, seeks to track the price and performance, excluding fees and expenses, of the WisdomTree BioRevolution ESG Screened Index (WTDNA), with an expense rate of 0.45%.
The ETF offers access to companies associated with BioRevolution activities through investment in listed companies that are expected to lead the transformations and advancements of genetics and biotechnology, and meet ESG (environmental, social and governance) criteria. by WisdomTree.
“The biology revolution is creating a historic investment opportunity equivalent to the Internet and industrial revolutions,” he stated. Chris Gannatti, Global Head of Analytics at WisdomTree. “Advances in biotechnology could represent the greatest innovations of our lives. The biology revolution has enormous potential to address and mitigate some of the most pressing challenges facing humanity today, be it climate change, food shortages, or disease and pandemic control. New and transformative innovations could have a profound impact on society and the environment, improving the quality of life for many ”.
WisdomTree leverages the knowledge provided by Dr. Jamie Metzl, one of the world’s leading futuristic technologists and Special Strategist for WisdomTree, in his construction of the WisdomTree BioRevolution ESG Screened Index, which identifies key sectors and industries that are expected to are the most transformative due to advances in biological science and technology.
“The revolutions in genetics and biotechnology will not only change our health systems, allowing us to live healthier and longer lives,” explained the Dr. Jamie Metzl, author of Hacking Darwin: Genetic Engineering and the Future of Humanity. “They will also fundamentally transform our world well beyond healthcare. The same technologies that drive innovation in healthcare will have a seismic impact on industries such as agriculture, materials, energy, and information processing, revolutionizing the ways we treat disease, grow food, produce materials, and process. data. If the 19th century was the century of chemistry and the 20th of physics, the 21st will be the century of biology. I am delighted to collaborate with the incredible team at WisdomTree and discover some of the opportunities that this historic megatrend presents. ”
The WDNA is the fifth ETF in WisdomTree’s UCITS thematic range that also comprises ETFs that provide exposure to the themes of artificial intelligence, cloud computing, cybersecurity and battery technology. WisdomTree’s UCITS themed range, launched in 2018 with just one product, now has $ 1.8 billion in assets under management.
Alexis Marinof, Head of Europe at WisdomTreeHe adds: “Our approach of partnering with experts to build indices within our range of thematic products has resonated with investors and delivered strong returns. This approach has contributed to the construction of a platform of $ 1.8 billion of differentiated thematic products that provide a pure and transparent exposure to the subject through an ETF. The WDNA brings together all the elements of the biology revolution and is at the sweet spot of innovation and diversification. “
WDNA: main features
The WisdomTree BioRevolution UCITS ETF merges qualitative and quantitative assessments of eligible securities in an effort to identify a portfolio of the best companies working at the forefront of these biological advancements through the following themes:
- Human health: The application of genetic technologies for the prevention and treatment of diseases will lead to significant improvements in human health, well-being and longevity, with the development of vaccines being a prominent example.
- Agriculture and Food: The revolutions in genetics and biotechnology will progressively transform agriculture, aquaculture and food production, generating healthier and more sustainable models to feed our growing population.
- Materials, Chemicals and Energy: Biological reengineering will be used to produce a higher percentage of physical results needed for manufacturing.
- Biological Machinery and InterfacesDNA has a storage capacity approximately 1 million times greater than a hard disk.
The WDNA is registered for sale in Austria, Denmark, Finland, Germany, Ireland, Italy, Luxembourg, the Netherlands, Spain, Sweden and the United Kingdom.